13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 83 holding rows worth $249,722,452.
- Accession
- 0001440771-26-000002
- Filer
- CIK 1440771
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 83 entries on the cover page, a total value of $249,722,452 stated on the cover page (in dollars after the unit check, H1), rows summing to $249,722,452 with VALUE read as dollars as filed, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 400,000 | $51,092,000 | dollars as filed | put |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 400,000 | $51,092,000 | dollars as filed | call |
| VERASTEM INC | 92337C203 | COMMON STOCK | 3,302,300 | $17,502,190 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 975,200 | $15,593,448 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,150,000 | $10,361,500 | dollars as filed | call |
| EVOLUS INC | 30052C107 | COM | 1,759,091 | $7,229,864 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 740,000 | $6,667,400 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 1,389,622 | $6,128,233 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 85,000 | $6,115,750 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 100,000 | $5,272,000 | dollars as filed | call |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 480,000 | $4,473,600 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 383,462 | $3,600,708 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 746,587 | $3,344,710 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 50,000 | $2,839,000 | dollars as filed | call |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 345,179 | $2,568,132 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 713,845 | $2,441,350 | dollars as filed | |
| ALEXANDRIA REAL ESTATE EQ INC COM | 015271109 | REIT | 50,000 | $2,321,000 | dollars as filed | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 100,000 | $2,226,000 | dollars as filed | call |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 27,778 | $2,200,573 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 69,500 | $2,180,215 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 792,289 | $2,162,949 | dollars as filed | |
| CURIS INC | 231269309 | COM | 3,726,406 | $2,039,462 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 420,000 | $1,726,200 | dollars as filed | call |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 280,000 | $1,624,000 | dollars as filed | call |
| TELA BIO INC | 872381108 | COM | 2,617,252 | $1,622,696 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 957,202 | $1,608,099 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 85,000 | $1,561,450 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 221,955 | $1,511,514 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 335,309 | $1,384,826 | dollars as filed | |
| OKYO PHARMA LTD | G6724L116 | SHS NEW | 850,000 | $1,368,500 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 100,000 | $1,263,000 | dollars as filed | call |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 500,000 | $1,225,000 | dollars as filed | call |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,402,191 | $1,121,893 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 768,288 | $991,092 | dollars as filed | |
| IN8BIO INC | 45674E208 | COM NEW | 663,412 | $981,850 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 500,000 | $975,000 | dollars as filed | call |
| SURROZEN INC | 86889P208 | COMMON STOCK | 33,005 | $961,436 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 200,000 | $940,000 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 200,000 | $940,000 | dollars as filed | call |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 100,000 | $928,000 | dollars as filed | call |
| ARDELYX INC | 039697107 | COM | 150,000 | $898,500 | dollars as filed | call |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 708,102 | $878,046 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 50,000 | $874,500 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 310,000 | $812,200 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,000,000 | $800,100 | dollars as filed | call |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 51,000,000 | $738,977 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 1,004,673 | $705,783 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 417,994 | $681,330 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 597,682 | $657,450 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 134,060 | $643,488 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 269,100 | $629,694 | dollars as filed | |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 831,301 | $616,659 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 100,000 | $563,000 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 50,010 | $555,611 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 132,578 | $548,873 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 64,162 | $539,602 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 99,735 | $527,598 | dollars as filed | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 102,500 | $502,250 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 100,000 | $448,000 | dollars as filed | call |
| PRECISION OPTICS CORP INC MA | 740294400 | COM NEW | 100,000 | $439,000 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 53,460 | $352,836 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 6,000 | $340,680 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 35,000 | $315,000 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 68,688 | $312,530 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 27,500 | $291,500 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 224,650 | $283,059 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 20,000 | $278,000 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 164,045 | $257,551 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 40,030 | $232,174 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 104,300 | $222,159 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 100,000 | $195,000 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 50,000 | $191,500 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 14,964 | $188,995 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 30,000 | $156,900 | dollars as filed | |
| CNS PHARMACEUTICALS INC | 18978H508 | COM | 61,000 | $145,790 | dollars as filed | |
| PROCESSA PHARMACEUTICALS INC | 74275C403 | COM SHS | 55,000 | $138,875 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 50,000 | $134,500 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 20,400 | $117,708 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 35,000 | $107,800 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 40,000 | $88,800 | dollars as filed | |
| EVAXION AS | 29970R303 | SPONSORED ADS | 19,713 | $73,332 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 16,300 | $39,935 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 65,387 | $10,527 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001440771-26-000002 | this filing | 2026-05-14 | acceptance time not in the bulk data set |